Stemline Therapeutics (United

Company snapshot

The Menarini Group ("Menarini"), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused on bringing transformational oncology treatments to people living with cancer. Inspired by the goal to improve outcomes for those with unmet medical needs, Menarini Stemline is driven to discover and develop

• 7 active pipeline program(s) linked via ClinicalTrials.gov.
• 7 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Stemline Therapeutics (United. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Stemline Therapeutics (United.

1. Jun 8, 2026 Clinical update

   STML-ELA-0322 — Phase 2

2. Jun 8, 2026 Clinical update

   ​​MEN2501-01​ — Phase 1

3. Jun 8, 2026 Clinical update

   STML-ELA-0422 — Phase 3

4. Jun 8, 2026 Clinical update

   MEN2312-01 — Phase 1

5. Jun 8, 2026 Clinical update

   MEDOPP545 — Phase 3

View all clinical trial activity →

• What is Stemline Therapeutics (United?

  Stemline Therapeutics is a pharma organization headquartered in EU. Primary therapeutic focus areas include Brain Metastasis from Estrogen Receptor Positive, HER-2 Negative Breast Cancer, Acute Myeloid Leukemia, Advanced ER+/HER2- Breast Cancer, metastatic breast cancer, ​​Platin

• Is Stemline Therapeutics (United publicly traded?

  Stemline Therapeutics (United appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Stemline Therapeutics (United develop or market?

  We link 29 drug profile(s) where Stemline Therapeutics (United is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/stemline-therapeutics-b-v#company-drugs.

• What are the latest developments for Stemline Therapeutics (United?

  In the last 12 months our linked public records show 7 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Stemline Therapeutics (United focus on?

  Stemline Therapeutics (United focuses on Brain Metastasis from Estrogen Receptor Positive, HER-2 Negative Breast Cancer, Acute Myeloid Leukemia, Advanced ER+/HER2- Breast Cancer based on our analysis of their pipeline programs and drug development activities.